Skip to main content
. 2017 Nov 6;9(10):8887–8897. doi: 10.18632/oncotarget.22322

Figure 3. Determination of Mimic-1 half-life and IC50 concentration using HCT116 colon cancer cell lines.

Figure 3

(A) Mimic-1 is more potent then unmodified miR-129 on colon cancer cells. (B) The IC50 for Mimic-1 is 11.71 nM compared to 43.2 nM for miR-129. (C, D) Mimic-1 is more stable than miR-129. (E) Formation of the FdUMP-TS complex (the upper shift-band) with 5-FU released from the degraded Mimic-1 is shown by Western immunoblot. (**p<0.01).